(Q39165145)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Vaccination with anti-idiotype antibody ganglidiomab mediates a GD(2)-specific anti-neuroblastoma immune response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Christiane A. Helm

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Holger N Lode

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Manuela Schmidt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Diana Seidel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Nicole Huebener

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Diana Brackrock

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Matthias Bleeke

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Daniel Reker

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Hans-Peter Mueller

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Nikolai Siebert

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

17 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

999-1010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591980%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00262-013-1413-y

28 February 2020

exact match

0 references

cites work

Disialoganglioside directed immunotherapy of neuroblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1413-Y

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1413-Y

Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1413-Y

Anti-idiotype antibody vaccine therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1413-Y

Phase I clinical trial on adjuvant active immunotherapy of human gliomas with GD2-conjugate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1413-Y

Characterization of GD2 peptide mimotope DNA vaccines effective against spontaneous neuroblastoma metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1413-Y

NK cells engineered to express a GD2 -specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1413-Y

Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1413-Y

Rapid cloning of rearranged immunoglobulin genes from human hybridoma cells using mixed primers and the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1413-Y

Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1413-Y

A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1413-Y

Construction and characterization of DNA vaccines encoding the single-chain variable fragment of the anti-idiotype antibody 1A7 mimicking the tumor-associated antigen disialoganglioside GD2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1413-Y

Recent advances in developing synthetic carbohydrate-based vaccines for cancer immunotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1413-Y

Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1413-Y

Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1413-Y